Annual Operating Expenses
$58.41 M
+$6.51 M+12.54%
31 December 2023
Summary:
Immuneering annual total operating expenses is currently $58.41 million, with the most recent change of +$6.51 million (+12.54%) on 31 December 2023. During the last 3 years, it has risen by +$23.60 million (+67.79%). IMRX annual operating expenses is now at all-time high.IMRX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$15.27 M
+$360.90 K+2.42%
30 September 2024
Summary:
Immuneering quarterly total operating expenses is currently $15.27 million, with the most recent change of +$360.90 thousand (+2.42%) on 30 September 2024. Over the past year, it has dropped by -$13.42 million (-46.76%). IMRX quarterly operating expenses is now -46.76% below its all-time high of $28.69 million, reached on 31 December 2023.IMRX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IMRX Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -46.8% |
| 3 y3 years | +67.8% | +37.6% |
| 5 y5 years | +735.9% | - |
IMRX Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +67.8% | -46.8% | +37.6% |
| 5 y | 5 years | at high | +735.9% | -46.8% | +340.5% |
| alltime | all time | at high | +735.9% | -46.8% | +340.5% |
Immuneering Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $15.27 M(+2.4%) |
| June 2024 | - | $14.91 M(-2.7%) |
| Mar 2024 | - | $15.33 M(-46.6%) |
| Dec 2023 | $58.41 M(+12.5%) | $28.69 M(+106.0%) |
| Sept 2023 | - | $13.93 M(+3.1%) |
| June 2023 | - | $13.51 M(-7.5%) |
| Mar 2023 | - | $14.60 M(+4.4%) |
| Dec 2022 | $51.90 M | $13.99 M(+5.9%) |
| Sept 2022 | - | $13.21 M(+13.0%) |
| June 2022 | - | $11.69 M(-10.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $13.02 M(+17.3%) |
| Dec 2021 | $34.81 M(+92.2%) | $11.10 M(+26.0%) |
| Sept 2021 | - | $8.81 M(+5.7%) |
| June 2021 | - | $8.33 M(+26.7%) |
| Mar 2021 | - | $6.58 M(+9.1%) |
| Dec 2020 | $18.11 M(+159.2%) | $6.03 M(+26.4%) |
| Sept 2020 | - | $4.77 M(+23.8%) |
| June 2020 | - | $3.85 M(+11.0%) |
| Mar 2020 | - | $3.47 M |
| Dec 2019 | $6.99 M | - |
FAQ
- What is Immuneering annual total operating expenses?
- What is the all time high annual operating expenses for Immuneering?
- What is Immuneering quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Immuneering?
- What is Immuneering quarterly operating expenses year-on-year change?
What is Immuneering annual total operating expenses?
The current annual operating expenses of IMRX is $58.41 M
What is the all time high annual operating expenses for Immuneering?
Immuneering all-time high annual total operating expenses is $58.41 M
What is Immuneering quarterly total operating expenses?
The current quarterly operating expenses of IMRX is $15.27 M
What is the all time high quarterly operating expenses for Immuneering?
Immuneering all-time high quarterly total operating expenses is $28.69 M
What is Immuneering quarterly operating expenses year-on-year change?
Over the past year, IMRX quarterly total operating expenses has changed by -$13.42 M (-46.76%)